Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy
Completed
- Conditions
- Prostate CancerCardiovascular Death
- Interventions
- Other: No intervention was required
- Registration Number
- NCT00651222
- Lead Sponsor
- Prostate Cancer Foundation of Chicago
- Brief Summary
The purpose of this study is to review cause of death in patients undergoing prostate brachytherapy at a single institution. Furthermore, we are analyzing patients undergoing androgen deprivation therapy and whether or not this contributed to cardiovascular deaths, specifically myocardial infarction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- Deceased anytime after prostate brachytherapy treatment
Exclusion Criteria
- Patients whose cause of death was unable to be determined
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 No intervention was required All deceased patients who underwent brachytherapy at Chicago Prostate Center between 10/14/1997 and 6/15/2007
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chicago Prostate Center
🇺🇸Westmont, Illinois, United States